Muthusamy Shanmugam - 28 Feb 2023 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
HEAD OF R&D, COO-NOVITIUM OPS, Director
Signature
/s/ Muthusamy Shanmugam, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
28 Feb 2023
Net transactions value
$0
Form type
4
Filing time
04 Apr 2023, 20:08:40 UTC
Previous filing
21 Mar 2022
Next filing
23 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Award $0 +17,369 +94% $0.000000 35,829 28 Feb 2023 Direct F1
transaction ANIP Common Stock Award $0 +11,578 +32% $0.000000 47,407 28 Feb 2023 Direct F2
holding ANIP Common Stock 1,332,620 28 Feb 2023 Held by Esjay LLC F3
holding ANIP Common Stock 5,000 28 Feb 2023 Held by Pharma LLC F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 28, 2023.
F2 These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting.
F3 The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
F4 The reporting person holds voting and dispositive power over the shares held by SS Pharma LLC

Remarks:

Exhibit-24 - Power of Attorney